Genetic evidence suggests that the Schistosoma mansoni genome contains six genes that encode α1,3-fucosyltransferases (smFuTs). To date, the activities and specificities of these putative fucosyltransferases are unknown. As Schistosoma express a variety of fucosylated glycans, including the Lewis X antigen Galβ1-4(Fucα1-3)GlcNAcβ-R, it is likely that this family of genes encode enzymes that are partly responsible for the generation of those structures. Here, we report the molecular cloning of fucosyltransferase-F (smFuT-F) from S. mansoni, as a soluble, green fluorescent protein fusion protein and its acceptor specificity. The gene smFuT-F was expressed in HEK freestyle cells, purified by affinity chromatography, and analyzed toward a broad panel of glycan acceptors. The enzyme product of smFuT-F effectively utilizes a type II chain acceptor Galβ1-4GlcNAc-R, but notably not the LDN sequence GalNAcβ1-4GlcNAc-R, to generate Lewis X type-glycans, and smFuT-F transcripts are present in all intramammalian life stages.
Introduction
Schistosomiasis is a debilitating vascular disease caused by an infection with parasitic helminths of the Schistosoma species. It causes a wide range of clinical manifestations that dramatically affect quality of life and is a major public health concern in over 70 tropical and subtropical countries. The World Health Organization considers schistosomiasis second in socioeconomic importance among diseases worldwide and the third most important parasitic disease in terms of public health impact Daumerie et al. 2010; Hotez et al. 2010; Elbaz and Esmat 2013) . Despite years of research on schistosome biology, millions are still infected and many more at risk due to insufficient prevention, diagnostics, treatments, and the absence of a vaccine.
All life stages of Schistosoma species produce abundant glycoconjugates on their surfaces and in secretions that are exposed to the host immune system. In fact, the S. mansoni cercarial glycocalyx is mostly carbohydrate by weight (Samuelson and Caulfield 1985; Caulfield et al. 1987 ). The glycome includes many N-and O-glycans linked to proteins, and glycolipids, which are structurally distinct from their definitive host. It has long been accepted that glycans and glycoconjugates may be bioactive, and many of the schistosome glycans are known to interact with the host immune system in a variety of complex mechanisms, most of which are poorly understood Nyame 1996, 1999; Hokke and Yazdanbakhsh 2005; Cummings 2006, 2010; Prasanphanich et al. 2013) .
A major constituent of the Schistosoma glycome is L-fucose. Fucose is abundant in N-and O-glycans in glycoproteins and in glycolipids of S. mansoni, and has been found in α1, 2-, α1,3-, α1,4-and α1,6-linkages (Cummings and Nyame 1999; Ma et al. 2006; Smit et al. 2015) . Fucosylated glycoconjugates are prominently involved in the host humoral and cellular immune responses to infection. Antibodies have been identified against a diverse group of immunologically important fucosylated structures on nonreducing ends of proteinand lipid-conjugated oligosaccharides in both mammalian and snail host-associated developmental stages in infected animals and humans. These glycans include LDNF (GalNAcβ1-4(Fucα1-3)GlcNAc), LDN-DF (GalNAcβ1-4(Fucα1-2Fucα1-3)GlcNAc), F-LDN (Fucα1-3GalNAcβ1-4GlcNAc), F-LDN-F (Fucα1-3GalNAcβ1-4(Fucα1-3) GlcNAc), DF-LDN-DF (Fucα1-2Fucα1-3GalNAcβ1-4(Fucα1-2Fucα1-3)GlcNAc) and Lewis X (Le X ; Galβ1-4(Fucα1-3)GlcNAc) (Khoo et al. 1997; Nyame et al. 2000; van Remoortere et al. 2000 van Remoortere et al. , 2001 Wuhrer et al. 2002; Naus et al. 2003; Robijn et al. 2005; Peterson et al. 2009; van Diepen et al. 2012) . The genes encoding potential fucosyltransferases have been partly identified recently (Trottein et al. 2000; Peterson et al. 2013; Mickum et al. 2014 ), but as of yet, there is no information about the enzymatic activities and specificities for these putative smFuTs. The lack of information has created a major limitation in the study of the functions of the fucosylated glycans and how they interact with the host, due to an inability to use enzymatic approaches to synthesize the unusual fucosylated glycans in an affordable and facile manner. The first phase of sequencing the S. mansoni genome in 2009 identified over 20 genes encoding putative fucosyltransferase (FuTs), many of which are predicted to be putative α1,3-or α1,6-FuTs. However, analysis of the corresponding database showed incomplete gene sequences and truncated, possibly non-functional enzymes which required further work to identify the full-length gene transcripts (Berriman et al. 2009; Zerlotini et al. 2009; Mickum et al. 2014) . More recent studies have identified the potential breadth of the fucosyltransferase multigene family resulting in six α1,3-FuTs, six α1,6-FuTs and two O-FuTs. Interestingly, however, no putative α1,2-FuTs were identified (Fitzpatrick et al. 2009; Peterson et al. 2013 ), although such linkages of Fucα1-2Fucα1-3-R are known to occur in S. mansoni glycoproteins and glycolipids. This raises a question as to whether some of the putative α1,3-or α1,6-FuTs might actually have α1,2-FuT activities, or if the α1,2-FuTs have been grouped in another glycosyltransferase family. As previously stated, the functions and biosynthesis of fucosylated oligosaccharides in schistosomes are not yet understood. To learn more about the biosynthesis, regulation and expression of fucosylated epitopes, we focused on the characterization of the S. mansoni α1,3-FuT family. In this report, we describe our study of the enzymatic activity of the α1,3-FuT-F activity in S. mansoni (smFuT-F), which we found to be capable of synthesizing the terminal Le X structures. To our knowledge, this represents the first parasitic worm α1,3-fucosyltransferase heterologously expressed and characterized to date.
Results

Identification and cloning of a possible Lewis-type fucosyltransferase
Several recent studies have taken a genomic/transcriptomic approach to identify and explore the fucosyltransferase multigene family in S. mansoni, which has previously been incompletely annotated in the gene database (Fitzpatrick et al. 2009; Zerlotini et al. 2009; Peterson et al. 2013) . Peterson et al. (2013) recently determined the extent of the FuT family by elucidating the full-length gene transcripts for seven putative α1,3-FuT genes (FuT-A-G) resulting in five new fulllength transcripts (FuT-B-F), one previously identified FuT (FuT-A) (Trottein et al. 2000) , and one pseudogene (FuT-G). Phylogenetic and sequence analysis of the six putative FuT genes A-F suggest two lineages, which can be further divided into three tentative groups based on predicted functionality ( Figure 1A ). One lineage consists of a possible core FuT (FuT-C) and the other (FuT-A, -B, -D, -E and -F) may synthesize more distal glycan motifs (de Vries et al. 2001; Baboval and Smith 2002; Mollicone et al. 2009; Peterson et al. 2013) . However, further dissection of the larger grouping allowed us to tentatively separate out genes that have the highest identity with wellcharacterized Lewis-type FuTs in other species. Based on these observations, we predicted that FuT-F and FuT-E might generate various Lewis X motifs (Le X , poly-Le X ) in Schistosoma glycoconjugates, whereas the remaining genes may produce other fucosylated motifs (LDNF, FLDN, di-fucose, etc.) . Because of these relationships and predictions, we focused on S. mansoni FuT-F, also abbreviated smFuT-F. Typically in animal cells the α1,3-FuTs are Golgi-anchored, type-II transmembrane proteins featuring a single transmembrane domain (TMD), which is flanked by a short cytoplasmic N-terminal tail and a lumenal C-terminus that comprises a globular catalytic domain and a flexible hypervariable stem (Breton et al. 1998; de Vries et al. 2001; Ma et al. 2006; Peterson et al. 2013) . Sequence analysis of smFuT-F revealed the presence of these well-conserved domains found in α1,3-FuTs ( Figure 1B) . Importantly, smFuT-F contains the canonical GPD-fucose-binding sequence, YxFxL/VxFENSxxxxYx-TEK (Breton et al. 1998; Oriol et al. 1999; Ma et al. 2006) . Analyses of transmembrane topology with TMHMM Server v. 2.0 suggest that smFuT-F is a traditional type-II transmembrane protein containing a single N-terminal TMD. Using NetNGlyc 1.0, there are five predicted N-glycosylation sites at asparagine (N) residues with the sequon NxS/ T where x≠P. The presence of a DXD motif is conserved among glycosyltransferase enzymes and believed to play a role in metal ion binding and catalysis (Ünligil and Rini 2000; Boeggeman and Qasba 2002) . While markedly different than the motif of α1,3/4-FuTs in humans and other species, VxxHH(W/R)(D/E), Peterson et al. (2013) were able to annotate a region in the stem which may contribute to smFuT-F's acceptor specificity (Dupuy et al. 1999 (Dupuy et al. ,2004 . Thus, the encoded protein of smFuT-F contains all the hallmarks for a Golgilocalized type II membrane glycosyltransferase, which likely utilizes GDP-fucose as a donor sugar.
To determine whether the smFuT-F gene encodes a functional fucosyltransferase, we generated a truncated version of the gene (residues 53-435) to remove the TMD ( Figure 1B) , and added an N-terminal TEV cleavage sequon flanked by restriction enzyme cut sites. The synthetic gene was then inserted into the mammalian expression vector pGen2 and the resulting plasmid was smFuT-F-pGen2. The subsequent recombinant protein product, smFuT-F-green fluorescent protein (GFP), included a GFP domain, Avi and 8× His tags, and a T. cruzi signal peptide targeting smFuT-F-GFP for secretion into the media ( Figure 1C ).
Expression of smFuT-F-pGen2 generates a recombinant GFP fusion protein
Recombinant protein was generated by transient transfection of the expression construct, smFuT-F-pGen2, into HEK293f cells. Cells were monitored by flow cytometry and microscopy for GFP fluorescence at 24 h time-points. After 72 h, over 90% of transfected cells were strongly GFP positive ( Figure 1D and E). The expression and localization of the recombinant smFuT-F-GFP protein was confirmed by SDS-PAGE and western blotting using an antibody directed to the GFP superfolder protein domain. The immunoblot revealed a protein band with apparent MW between 70 and 100 kDa, which would be expected of a variably glycosylated polypeptide of 74.6 kDa predicted from the full-length GFP fusion protein ( Figure 1F) . Surprisingly, smFuT-F-GFP was not secreted into the media as we expected, and western blotting under nonreducing conditions revealed higher order oligomers ( Figure 1F ). Thus, it is possible that smFuT-F-GFP may be oligomerizing with itself or with other Golgi-localized proteins, or glycan acceptors that prevent its release from the cell. The lack of secretion has not been observed when Sequence analysis of smFuT-F revealed the presence of these well-conserved domains found in α1,3-FuTs including a TMD, five sites of potential N-glycosylation, canonical GDP-fucose-binding region, a metal-binding DXD motif and a possible sequence which could affect acceptor specificity. The truncation site for removing the TMD for pGen2 cloning is also annotated. (C) Cartoon depiction of the soluble (ss = T. cruzi secretion signal peptide), tagged (His tag and Avi Tag), GFP fusion protein (smFuT-F-GFP) that resulted from cloning of truncated smFuT-F into the pGen2 expression vector. GFP positivity of HEK freestyle cells by flow cytometry (D) and fluorescent microscopy (E), and after transfection or mock transfections (control) with smFuT-F-pGen2. By 72 h post-transfections, over 90% of transfected cells are expressing GFP and can be harvested for smFuT-F-GFP purification. (F) Anti-GFP western blot of smFuT-F-pGen2 transfected or control HEK cells and conditioned media 72 h post-transfection. smFuT-F-GFP is found in transfected cells but not secreted into the media, possibly due to the higher molecular-weight oligomers seen in nonreducing conditions. This figure is available in black and white in print and in color at Glycobiology online.
other, non-schistosomal, glycosyltransferase genes are expressed in the pGen2 vector (data not shown).
smFuT-F-GFP adds fucose to type II glycan chains
To characterize the activity of smFuT-F-GFP, it was purified from the HEK293f cells using Ni-NTA agarose and initially tested with a small panel of glycan acceptors. LacNAc (Galβ1-4GlcNAc; LN; N-acetyllactosamine), which contains a type II sequence, and LacdiNAc (GalNAcβ1-4GlcNAc; LDN) are common terminal motifs in Schistosoma glycoproteins; however, the additional modifications (sialylation, sulfation and fucosylation) often differ between host and parasite (Khoo et al. 1997; van den Eijnden et al. 1997; van de Vijver et al. 2006; van Die and Cummings 2010; Yoshino et al. 2012 Yoshino et al. ,2013 , e.g. schistosomes lack sialic acid. Previous work, based on glycan structural analyses, indicated that Schistosoma α1,3-or α1,4-FuTs might preferentially utilize type II glycan chains, since type I chains Galβ1-3GlcNAc are not found (Hokke et al. 1998; Marques et al. 2001; Ma et al. 2006) . To this end, and to compare type I versus type II chains, we selected LNnT, lacto-N-tetraose (LNT), LDN and lactose (glycan sequences shown in Table I ) in our initial screening panel of acceptors (Figure 2A-D) . smFuT-F-GFP generated a product from the type II acceptor LNnT ( Figure 2A , Table I ). The smFuT-F product from LNnT was examined by matrix-assisted laser desorption/ionizationtime of flight (MALDI-TOF); the size confirmed that a single fucose had been added-size shift from 1202.58 to 1375.93 m/z ( Figures 2E and 3F) . It was unclear, however, which residue was modified by fucose; interestingly, the lack of product generated from lactose suggested one of the more distal sugars, GlcNAc or galactose, may be the location of the added fucose. In addition, no detectable product was found for reactions involving the oligosaccharides LNT, LDN or lactose ( Figure 2B -D, Table I ).
To determine linear sequence and branching of the LNnT product from the smFuT-F reaction, a multistage MS n analysis was used after chemical removal of the 2-amino-N-(2-aminoethyl)benzamide (AEAB) tag and sample methylation. The MS 2 spectrum of a singly charged [M+Na] + precursor ion (1056.60 m/z) of the pentasaccharide
LNnT smFuT-F product is shown in Figure 3A . Major fragmentations are diagrammed, showing the ions represented by cleavage of the glycosidic bonds ( Figure 3B ) (Domon and Costello 1988; Sheeley and Reinhold 1998; Ceroni et al. 2008) . The peak at 660.33 m/z matches the calculated mass of a trisaccharide comprised of Galβ1-4GlcNAc with a fucose of undetermined location. From the MS 2 spectrum ( Figure 3A) , peak 660.33 m/z was isolated and selected as the precursor ion for MS 3 ( Figure 3C ). Spectral analysis determined the peak pattern consistent with both glycosidic and cross-ring fragmentation of Galβ1-4(Fucα1-3)GlcNAc ( Figure 3D ) (Domon and Costello 1988; Sheeley and Reinhold 1998; Ceroni et al. 2008) . The predicted structure for the LNnT smFuT-F product is illustrated in Figure 3E .
smFuT-F generates the Lewis X motif
To confirm the fucose-GlcNAc bond orientation produced by smFuT-F-GFP, LNnT smFuT-F product or mock-reacted LNnT was high-performance liquid chromatography (HPLC) purified, conjugated to beads and stained with highly defined lectins and monoclonal antibodies (mAbs). Carboxyl beads were activated with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysulfosuccinimide (sulfo-NHS) to form amine-reactive sulfo-NHS esters which conjugates to the bifunctional linker AEAB with high efficiency (Song et al. 2009 ). To verify the conjugation of glycans to the beads, biotinylated Gal-and Fuc-specific lectins (RCA-I, AAL) were used to confirm the presence of mock reacted LNnT and a fucosylated LNnT smFuT-F product ( Figure 4 ). As the presence of fucose on the product of smFuT-F using LNnT as the acceptor was confirmed by both mass spectrometry and lectin binding, we utilized highly specific anti-glycan antibodies to confirm the motif and, by extension, the glycosidic bond orientation. To test the generation of Le X , we used mAb F8A1.1, which binds terminal motifs, and L6B8, an anti-LDNF antibody, acted as an isotype control ( Figure 4 ) (Mandalasi et al. 2013; Prasanphanich et al. 2014) . The smFuT-F reaction product beads bound F8A1.1 and did not bind the control antibody, confirming the glycans sequence of the enzyme product is Galβ1-4(Fucα1-3)GlcNAc and the Le X epitope generating the structure LNFPIII from LNnT and confirming the product predicted in Figure 3E .
Acceptor specificity of smFuT-F-GFP
To determine the range of type II glycan acceptors that smFuT-F-GFP might utilize, a panel of five additional acceptors with further modifications on linear chains and branched structures were tested (glycan sequences shown in Table I ; Figure 5 ). Despite previous work showing Schistosoma α1,3/4-FuTs are able to utilize α2,3-sialylated type II structures, smFuT-F-GFP did not efficiently fucosylate LSTd, an α2,3-sialylated LNnT structure ( Figure 5A , Table I ) (Marques et al. 2001; Ma et al. 2006 ). However, this may not be surprising as S. mansoni neither synthesizes sialic acid nor acquires it from their hosts 
Glycan sequence, shorthand and relative activity of recombinant smFuT-F-GFP towards each glycan tested. Glycan acceptor demonstrating the highest activity was set at 100%.
n.d., no detectable activity towards that acceptor. (Cummings and Nyame 1999; Prasanphanich et al. 2013) . Mass spectra of the LSTd product were consistent with LNnT results as MALDI-TOF MS causes loss of sialic acid ( Figure 5C ) (Powell and Harvey 1996; Harvey 2011) . Schistosoma express Le X terminally and within poly-Le X structures comprised both internal and terminal motifs (van Dam et al. 1996; Mandalasi et al. 2013; Mickum et al. 2014) . To determine whether smFuT-F-GFP generates one or both of these structures, we examined its reactivity to poly-N-acetyllactosamine-type glycan, PLNnH ( Figure 5B ). The minor reaction product 1 had the mass equivalent with PLNnH plus two fucose residues, whereas the major product 2 acquired a single fucose which could have been on the internal or terminal LN (Galβ1-4GlcNAc) sites ( Figure 5D and E). MS 2 spectrum of a singly charged [M+Na] + precursor ion (1505.74 m/z) of the PLNnH smFuT-F product 2 ( Figure 5F ) and spectral analysis of major peaks from both glycosidic and cross-ring fragmentation concluded that the fucose was located on the terminal LN ( Figure 5G ) (Domon and Costello. 1988; Sheeley and Reinhold 1998; Ceroni et al. 2008) . On the basis of these data, we propose the primary smFuT-F product generated from PLNnH is Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc depicted in Figure 5H , and that smFuT-F-GFP preferentially modifies terminal LN sites.
To explore the ability of smFuT-F-GFP to modify branched structures, LNH and LNnH, containing branches with type I and type II chains, were assessed as glycan acceptors. As expected from the LNT and LNnT results, smFuT-F-GFP added fucose to only one branch of LNH, likely the type II chain ( Figure 6A and C), with LNnH, which has two branches with type II structures, three products were generated ( Figure 6B ). From the mass spectrometry results, the first product has two fucose residues, suggesting that both branches were modified by smFuT-F-GFP ( Figure 6D ). The second and third products ( Figure 6E and F) contained a single fucose each on a different branch, which in combination with the orientation of the AEAB tag generated distinctive enough products to allow for the HPLC separation seen in Figure 6B . Similar results were obtained with the NA2 acceptor, which verified smFuT-F-GFP generation of Le X on N-glycans ( Figure 7 ). Overall activity of smFuT-F-GFP to the panel of glycan acceptors, and acceptor sequences, can be seen in Table I . As more potential glycan acceptors become available in the future it will be interesting to define their kinetic activities toward the smFuT-F. 
Temperature and cation requirement smFuT-F-GFP
Further analyses were conducted to find the optimum conditions for smFuT-F-GFP including activity assays that were carried out at room temperature or at 37°C due to the environmental conditions of the worm during a two-part (mollusk and mammalian) life cycle. Interestingly, the activity of smFuT-F-GFP was comparable at both temperatures (Table II) . As smFuT-F-GFP has a DXD motif, cation requirement assays for the smFuT-F-GFP were performed at room temperature (25°C) using a selection of metals at 20 mM (Table II) . Recombinant enzyme smFuT-F-GFP prefers Mn 2+ for optimum activity, whereas Ni 2+ greatly reduced its activity. Other metal ions, Mg
2+
and Ca 2+ , that might be utilized by glycosyltransferases also promote smFuT-F-GFP activity, however, to a lesser degree than seen with Mn 2 + . Similar levels of activity in the presence of ethylenediaminetetraacetic acid/ethylene glycol tetraacetic acid (EDTA/EGTA) and with no addition of metal chlorides. It is possible that smFuT-F co-purifies with a small amount of metal that cannot be removed by chelation, or that the enzyme mechanism is metal independent and stimulated by divalent cations through alternative means.
Expression of smFuT-F mRNA in various intramammalian life stages
The available information shows that there is an abundance of Le Xcontaining and other fucosylated glycans expressed in intramammalian life stages; there is great interest in elucidating their immunomodulatory roles in human and animal hosts (Ko et al. 1990; Srivatsan et al. 1992; Nyame et al. 1996 van Dam et al. 1996 van Die et al. 2003) . To explore the corresponding α1,3-FuT transcript expression, RT-qPCR of the FuT family was determined in cercariae, newly transformed somules, 3-day in vitro-cultured somules and adult worms (Figure 8 ). Real-time qPCR data indicate that FuT-F transcript abundance decreasing during maturation from larvae to adulthood, which inversely correlates with surface expression of Le X (Köster and Strand 1994; van Remoortere et al. 2000; Nyame et al. 2003; Mandalasi et al. 2013) . Similar trends are observed for FuT-E, which is also predicted to generate Lewis-type structures (Figures 1A and 8) . In contrast, FuT-A appears to increase along with transformation and subsequent culture, reaching its peak in adulthood. For FuT-C, transcript abundance briefly increased after mechanical transformation and then declined once the worms reached adulthood. No significant variations in transcript abundance were observed for FuT-B and FuT-D in these experiments.
Discussion
It has long been recognized based on glycan structural analyses that schistosomes contain an α1,3-FuT that fucosylates LN (Ga1β1-4GlcNAc) to generate the Le X determinant rather than acquiring it from blood, as has been proposed for several blood group antigens (Ko et al. 1990; Goldring et al. 1976; DeBose-Boyd et al. 1996; Srivatsan et al. 1992) . In schistosomes, the Le X antigen was first found on complex-type N-glycans of glycoproteins, but it also exists on lipids and secretions (Srivatsan et al. 1992; van Dam et al. 1996; Wuhrer et al. 2002) . Some glycans contain the repeating LN disaccharide within the sequence of poly-N-acetyllactosamine, which can have multiple sites of fucosylation on the GlcNAc residues generating the socalled poly-Le X structures (Srivatsan et al. 1992) . Poly-Le X has also been reported in O-glycans derived from circulating cathodic antigens (CCAs) and has more recently been investigated as an important antigen for diagnostics (van Dam et al. 1994 (van Dam et al. ,1996 van Roon et al. 2004; Sousa-Figueiredo et al. 2013) . Thus, it is important to identify, clone and biochemically characterize the FuTs that are responsible for biosynthesis of Le X and the extension of poly-Le X , on N-glycans and poly-Le X on O-linked CCA.
There is a need for developing a better understanding of the genetic basis of these polymeric antigens, as they are thought to be important antigenic targets, immunomodulators and, in the case of CCA, a validated diagnostic antigen (van Dam et al. 1994 (van Dam et al. ,1996 van Roon et al. 2004; Sousa-Figueiredo et al. 2013) . Previous information on FuTs in the gene database has been incompletely annotated; however, more recent studies have taken a glycomics approach to identify and explore the FuT family in S. mansoni (Fitzpatrick et al. 2009; Zerlotini et al. 2009; Peterson et al. 2013 ). In 2013, Peterson et al. (2013) published the full-length gene transcripts for six α1,3-FuT genes (FuT-A-F) allowing us to finally explore the functionality of schistosome FuTs and more accurately recapitulate portions of the schistosome glycome. Our study shows that the S. mansoni gene FuT-F (smFuT-F) is capable of generating the Le X antigen on linear and branched glycans (Figures 2-7 , Table I ). The sequence of FuT-F contains all the hallmarks of a type II transmembrane FuT ( Figure 1B ), but only sequence similarity to other well-characterized enzymes gave insight into its function. For example, amino acids in the hypervariable region of human FuTs determine acceptor specificity between type I and type II chains, with tryptophan (Trp) common for type I and arginine (Arg) for type II (Dupuy et al. 1999 (Dupuy et al. ,2004 . Peterson et al. (2013) were able to annotate a similar region in the S. mansoni FuT family stems, with the region in smFuT-F containing lysine (Lys) ( Figure 1B) . Two Helicobacter pylori FuTs also contain Lys, which is charged similarly to Arg, and utilize type II chains like smFuT-F-GFP (Figure 2 ) (Ge et al. 1997; Martin et al. 1997) . Given the differences among the six schistosome FuTs (Peterson et al. 2013) , the presence of Lys in the acceptor motif of FuT-F may be serendipitous. However, FuT-E which may also generate Lewis-type structures ( Figure 1A ), also contains Lys in the acceptor motif region, whereas FuT-A, -B, -C and -D do not (Peterson et al. 2013) . Recombinant smFuT-F-GFP adds fucose α1,3 to GlcNAc in LN motifs to produce the Le X structure (Figures 2-4) . A more extensive panel of glycan acceptors allowed us to further characterize the type of Lewis structures generated (Table I ). The relative amounts of product generated from each acceptor tested may provide some insight into the limitations of smFuT-F in regard to LN motifs it can fucosylate and its preferred acceptors. For example, only 6% of the LSTd acceptor gained a fucose compared with 94% for PLNnH (Table I, Figure 5A and B). It is clear that sialylation, a common modification of LN in mammals van Die and Cummings 2010) , is unfavorable for smFuT-F-GFP activity. PLNnH is a poly-N-acetyllactosamine-type glycan with an internal and terminal LN. Over 98% of the product generated contains a single fucose on the terminal LN, illustrating smFuT-F-GFP is unlikely to be responsible for synthesizing poly-Le X , a common schistosome glycan both on N-glycans and secreted as CCA ( Figure 5B , D-H) (Srivatsan et al. 1992; van Dam et al. 1994 van Dam et al. ,1996 . Thus, it is likely that one of the other FuTs has a complementary function to FuT-F and generates poly-Le X and/or CCA.
smFuT-F-GFP was also able to fucosylate branched glycans as well as Table I ). The presence of a type I chain did not prevent fucosylation of an available type II branch, as seen in the LNH reactions ( Figure 6A ). When both branches contained type II chains with terminal LN, such as LNnH and NA2, there was a clear preference for one branch compared with the second, but a significant amount of product was double fucosylated (Figures 6B and 7A ). In the future as more of these putative smFuTs are identified, their collective activities to a wide panel of acceptors will need to be explored. Fucosylated glycoconjugates are observed in all developmental stages of S. mansoni; however, previous studies report that much higher levels of FuT expression was found in egg extracts in comparison with cercarial or adult worm extracts, suggesting that FuT activities are differentially regulated during development (Marques et al. 2001; Ma et al. 2006 ). In the case of Le X expression, adult schistosomes synthesize the Le X determinant, whereas it appears to be absent or highly restricted in cercariae and freshly transformed schistosomula (Köster and Strand 1994; van Remoortere et al. 2000; Nyame et al. 2003; Mandalasi et al. 2013) . When comparing mRNA levels in various intramammalian stages, there was limited (2-fold maximum) variation between some but not all FuTs (Figure 8 ). The observed variation in transcript levels in these life stages is markedly different than the variation seen in snail-associated larvae, where transformation from miracidia to sporocytes correlated with a decrease in FuT expression for all genes (Peterson et al. 2013 ). However, Le X expression and localization in the intramolluscan stages are known to be developmentally regulated, whereas mother and daughter sporocysts do not express Le X (Nyame et al. 2002; Peterson et al. 2009 ). This may be reflected in the FuT-E transcript abundance, if future experiments prove it also functions as a Lewis-type FuT, but not for FuT-F where the decrease was minimal (Peterson et al. 2013 ). This suggests that glycan expression may be regulated in more complicated ways (i.e. tissue specific, internal vs. external expression) in which RT-PCR of whole organisms may not be the best methodology. It is also unclear if any significant changes in relative transcript amounts have any observable difference in glycan synthesis or abundance. Also, the above observations in our intramammalian samples and published data for intramolluscan larvae are both incongruous with the results of a preceding transcription study, possibly due to disparities in methodologies (Fitzpatrick et al. 2009 ). Obviously, future studies are needed on fucosylated glycan structures, antibody specificities for the Le X antigen, FuT-F protein expression and transcript utilization, to address the apparent lack of strict correlation between transcript expression for smFuT-F and expression of Le X . Also, with the recombinant smFuT-F enzyme, an antibody to the FuT-F enzyme could be generated in order to explore for protein expression as opposed to transcript levels.
It is not well understood what role the regulated expression of Le X glycan plays in the immunobiology of schistosomes. Some studies suggest that Le X may be expressed on glycans that contain an immunoregulatory function. The free sugar LNFPIII (Galβ1-4(Fucα1-3) GlcNAcβ1-3Galβ1-4Glc), which is the sugar smFuT-F generated from LNnT, is reported to stimulate macrophages in vitro to express CD69, secrete IFN-γ and activate NK cells (Atochina and Harn 2005) . van Die et al. (2003) reported that Le X glycans from SEA interact with the human dendritic cell lectin DC-SIGN. There is also evidence that Fig. 7 . Characterization of smFuT-F-GFP activity towards N-glycans acceptors. HPLC chromatograms of smFuT-F or mock reactions utilizing acceptor Na2 (A) separated over a PGC column. Three product peaks are noted by arrows. MALDI-TOF MS spectrum of smFuT-F LNH Na2 product 1 (m/z = 2694.37) (B) shows the accumulation of two fucose residues (Na2+2Fuc). MALDI-TOF MS for smFuT-F NA2 product 2 (m/z = 2520.42) (C) and smFuT-F NA2 product 3 (m/z = 2520.52) (D) which each correspond with a single fucose addition, likely on alternate branches. AEAB-labeled samples were peracetylated and permethylated prior to MALDI-TOF MS analysis. This figure is available in black and white in print and in color at Glycobiology online. Effects of temperature and divalent cations on recombinant smFuT-F-GFP activity. Divalent cation assays were conducted at room temperature (25°C). Glycan acceptor demonstrating the highest activity was set at 100%.
n.d., no detectable activity towards that acceptor.
Le X can also modulate the release of factors that mediate the Th-1 to Th-2 switch observed during chronic S. mansoni infections (Velupillai and Harn 1994) . However, infected humans and animals generate IgG and IgM antibodies to Le X (Ko et al. 1990; Srivatsan et al. 1992; Nyame et al. 1996) . Le X is a critical component of the ligands on neutrophils and monocytes recognized by selectins and important in inflammation and leukocyte recruitment (McEver and Cummings 1997) . Anti-Le X antibodies were shown to cause complementdependent cytolysis of leukocytes and possibly other Le X -expressing cells, suggesting that an autoimmune disorder may accompany schistosomiasis . However, Le X is only a small portion of the glycan repertoire on S.
mansoni surfaces and glycocalyces and secreted glycoconjugates that are exposed to the host immune system. Other structures including LDNF, FLDN, FLDNF, diF-LDN, etc., are relatively unique to the parasite, yet to be enzymatically or chemically synthesized, and prominently involved in the host humoral and cellular immune responses to infection (Khoo et al. 1997; Nyame et al. 2000; van Remoortere et al. 2000 van Remoortere et al. ,2001 Wuhrer et al. 2002; Naus et al. 2003; Robijn et al. 2005; Peterson et al. 2009; van Diepen et al. 2012) . Further studies on the function of schistosome α1,3-FuTs-A through E are currently underway to determine their role in fucosylated glycan synthesis and give insights into development of the worm and its possible function in the pathogenesis of the disease. The ability to produce the unique glycans of S. mansoni and more accurately recapitulate the fucosylated schistosome glycome will be an invaluable tool in the continued exploration of the roles schistosomal glycans play in both worm biology and their interactions with host species.
Materials and methods
Materials
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) and used without further purification unless otherwise noted. Water and Acetonitrile (HPLC grade) were purchased from Thermo Fisher Scientific (Waltham, MA). Expression vector pGen2 was generated by Dr. Kelley Moremen and the glyco-enzyme repository. Restriction enzymes and ligase were purchased from New England Biolabs, Inc.
(Beverly, MA). Primers were from Integrated DNA Technologies (Coraville, IA). Lacto-N-neotetraose (LNnT) and AEAB were synthesized (Song et al. 2009 ). LNT was purchased from V-labs, Inc. (Covington, LA). All other glycans were purchased from ELICITYL OligoTech (Grenoble, France). GDP-fucose was purchased from Carbosynth (Berkshire, UK). Polyethylenimine (PEI, 25 kDa linear, cat. # 23966) was purchased from Polysciences, Inc. and prepared as a stock solution at a concentration of 1 mg/mL in a buffer containing 25 mM HEPES, pH 7.5, and 150 mM NaCl. The anti-GFP antibody (clone GT859) was purchased from GeneTex (Irvine, CA) and the secondary antibody HRP conjugate goat anti-mouse was purchased from KPL (Gaithersburg, MD). SuperSignal West chemiluminescent substrates were purchased from Thermo Scientific (Rockford, IL). Plant lectins were purchased from Vector Labs (Burlingame, CA) including AAL, Aleuria aurantia lectin and RCA-I, Ricinus communis agglutinin I. An anti-LDNF antibody (IgG-clone L6B8) and an anti-Le X (IgG -clone F8A1.1) were developed as monoclonal antibodies by production of hybridomas from spleens of mice that had been infected with S. mansoni, as described previously (Nyame et al. 2000; Mandalasi et al. 2013) . Secondary antibody conjugate goat anti-mouse IgG Alexa-633 and Cy5-streptavidin (Cy5-SA) were from Invitrogen (Carlsbad, CA). An Ultraflex-II MALDI-TOF/TOF system from Bruker Daltonics (Billerica, MA) was used for analysis of glycan conjugates. An Orbitrap Fusion Tribrid system from Thermo Fisher Scientific (San Jose, CA) was used for MS n fragmentation analysis of glycans. A FACSCalibur from BD Biosciences (San Jose, CA) with CellQuestPro acquisition software was used for flow cytometry, and FlowJo software was used for data analysis.
Cloning of S. mansoni FuT-F
The coding region for truncated S. mansoni FuT-F, smFuT-F (residues 53-435) was synthesized by Genewiz, Inc (South Plainfield, NJ) with an additional NH2-terminal fusion of the seven amino acid recognition sequence of the tobacco etch virus (TEV) protease. The synthetic DNA contained a flanking 5′ EcoRI and 3′ BamHI sites and was subcloned into similarly digested chemically synthesized vector, termed pGen2, containing the following features: promoter, intron, postregulatory element, termination and terminal repeat sequences (Barb et al. 2012; Zhang et al. 2013) . The coding region of the resulting fusion protein was comprised of a 25 amino acid NH2-terminal signal sequence from the T. cruzi lysosomal α-mannosidase followed by an 8× His tag, 17 amino acid AviTag, "superfolder" GFP, TEV protease cleavage site and truncated smFuT-F (Vandersall-Nairn et al. 1998; Beckett et al. 1999; Pédelacq et al. 2006 ). This expression vector was designated smFuT-F-pGen2 and the recombinant product termed smFuT-F-GFP.
Expression of smFuT-F-pGen2 in HEK freestyle cells
To determine if smFuT-F-pGen2 encoded a soluble, active α1,3-FuT, smFuT-F-pGen2 was transiently transfected into HEK freestyle cells (HEK293f, Life Technologies, Grand Island, NY). Cells were grown to a density of 2.5 × 10 6 cells/mL in Freestyle 293 Expression Medium (Life Technologies) in suspension on a platform shaker in a humidified 37°C incubator. Before transfection, cells were spun down at 300 × g for 5 min and re-suspended in fresh media. To generate the transfection solutions, smFuT-F-pGen2 was diluted to 4 µg/mL in Freestyle 293 Expression Medium and PEI was diluted to 9 µg/mL for a final concentration of 0.5 µg DNA or PEI/µL media in transfection solution. The DNA solution was added to cells, and the culture allowed to shake in 37°C incubator for 5 min. The PEI solution was then Fig. 8 . α1,3-Fucosyltransferase gene transcription in intramammalian S. mansoni life stages. Real-time qPCR was used to examine steady-state levels of α1,3-FuT transcription in cercariae (cerc), newly transformed schistosomula (new som), 3-day in vitro-cultured schistosomula (3day som) and adults. Transcript abundance in larval stages was assessed relative to adults, which was arbitrarily set at 1. Data represent the average of three independent biological replicates, and star (*) indicates significantly altered gene transcription (P < 0.05). This figure is available in black and white in print and in color at Glycobiology online.
added and the cells returned to the shaking incubator. After 24 h, the cells were diluted 1:1 with fresh media and supplemented with valproic acid (Sigma-Aldrich, #4543) to a final concentration of 2.2 mM. Cells were monitored via flow cytometry by gating on live cells and monitoring GFP positivity at 24 h time-points. As a control, HEK293f cells were mock transfected under similar conditions with PEI alone (no DNA). After 72 h, media was clarified by centrifugation at 3,000 × g for 10 min. Conditioned media and cell pellets were stored at −20°C prior to use.
SDS-PAGE and western blot of smFuT-F-GFP expression
For SDS-PAGE and western blotting, 15 µL aliquots of transfection culture or control culture were sampled. Cells were pelleted by centrifugation at 10,000 × g for 5 min and conditioned media was retained. Cells were suspended in 15 µL of fresh media. 1 × NuPAGE SDS sample buffer (Invitrogen) with or without 2.5% β-mercaptoethanol was added to conditioned media or cells boiled for 10 min. Samples were run in 10-well Mini-PROTEAN-TGX gels at 110 V with broad range protein standards (Spectra multicolor). Protein was transferred to a nitrocellulose membrane using Trans-Blot Turbo semi-dry transfer system. Unless noted otherwise, all subsequent incubations and washes were shaking at ambient temperature. Membranes were blocked for 1 h in 5% (w/v) bovine serum albumin (BSA) fraction V in TBS wash buffer (20 mM Tris, 300 mM NaCl, 0.05% Tween-20).
Membrane was washed three times with TBS wash buffer and incubated with anti-GFP antibody 1:10,000 in 1% (w/v) BSA in TBS wash buffer. The membrane was then washed three times in TBS wash buffer. Secondary detection antibody, HRP-conjugated goat anti-mouse IgG, was added for 1 h at 1:20,000 in TBS wash buffer. The same wash procedure was repeated, and then SuperSignal West Pico Chemiluminescent Substrate was added for 30 s. The membranes were dabbed dry and exposed to film.
Purification of recombinant smFuT-F-GFP
Cell pellets were re-suspended in a Binding Buffer (50 mM NaH 2 PO 4 , 150 mM NaCl, 10 mM imidazole, 2% (v/v) Tween-20, 1× EDTA protease inhibitor, pH 8.0) and sonicated over ice to lyse cells. Insoluble debris was removed by centrifugation at 10,000 × g for 10 min. The pellet was re-suspended in Binding Buffer, sonicated and spun down two more times. The supernatant was adjusted to 0.5% Tween-20 with detergent free Binding Buffer and loaded onto a column containing 1 mL Ni-NTA superflow (Qiagen, Valencia, CA) equilibrated with wash buffer (50 mM NaH 2 PO 4 , 500 mM NaCl, 20 mM imidazole, pH 8.0). Following the loading of the sample, the column was washed with 50 mL of Wash buffer and eluted in 2 mL fractions with Elution buffer (50 mM NaH 2 PO 4 , 500 mM NaCl, 500 mM imidazole, pH 8.0). Fractions containing GFP were pooled and dialyzed into 25 mM HEPES, 300 mM NaCl, 50 mM imidazole, pH 7.5 with a 10 kDa molecular weight cutoff. The dialyzed samples was concentrated using Amicon Ultra 0.5 mL Centrifugal Filters with 10 kDa molecular weight cutoff (Millipore). Final protein concentration was determined by BCA assay.
Glycan AEAB labeling and purification
Glycan acceptors were selected and conjugated with AEAB as described previously (Song et al. 2009; Smith and Cummings 2013; Yu et al. 2014) . Briefly, 1-10 mg of glycan was mixed with 50-250 µL of freshly prepared 0.35 M AEAB hydrochloride salt and an equal volume of 1 M NaCNBH 4 in dimethyl sulfoxide (DMSO)/ AcOH (v/v = 7/3). The conjugation reaction was left to proceed for 2 h at 65°C and was stopped by the addition of 10 volumes of cold acetonitrile and allowed to stand for 30 min at −20°C. The precipitated glycan AEAB (GAEAB) derivatives were collected after centrifugation at 10,000 × g for 5 min. The GAEAB pellet was dried under a vacuum for 10 min, reconstituted in water, and centrifuged at 10,000 × g for 2 min to remove any insoluble material. A Shimadzu HPLC CBM-20A system coupled with a fluorescence detector RF-10AXL (330 nm/420 nm excitation/emission) was used for HPLC analysis and separation of GAEABs. The GAEABs were purified by reverse phase HPLC on a porous graphitized carbon column (PGC; 150 × 4.6 mm, Thermo Fisher Scientific) with a gradient of 15-45% acetonitrile (0.1% trifluoroacetic acid) in 40 min to separate the GAEABs from any unincorporated label. The effluents were monitored by fluorescence where the GAEAB peak fractions were collected, quantified by fluorescence and dried under vacuum. GAEABs were reconstituted to 1-5 mM stocks in water and stored at −20°C until use.
Fucosyltransferase assays
The fucosyltransferase assays were performed in 50 µL reaction mixtures containing 50 mM sodium cacodylate, pH 7.0, 20 mM MnCl 2 (or other metal salt), 4 mM GDP-fucose, 4 µM GAEAB sugar acceptor and smFuT-F-GFP. No smFuT-F-GFP was added for mock reaction conditions. Reaction mixtures were incubated rotating at room temperature or 37°C for 4 days. The enzyme was removed from the reaction mixture via porous graphitized carbon solid-phase extraction. Fucosyltransferase GAEAB products were then separated from GAEAB acceptors by reverse phase HPLC on a PGC column. Each peak fraction was collected, quantified by fluorescence and dried under vacuum. Samples were then processed for either MALDI-TOF MS for molecular mass analysis or Electrospray Ionization Mass spectrometry (ESI MS) for MS n fragmentation.
Mass spectrometry of FuT products
For MALDI-TOF MS analysis, purified fucosyltransferase GAEAB products were acetylated using acetic anhydride in saturated sodium bicarbonate for 30 min on ice, followed by room temperature incubation for 1 h. Glycans were then desalted via porous graphitized carbon solid-phase extraction. Any esters formed during acetylation were hydrolyzed by incubation in 0.01 M sodium hydroxide at room temperature for ∼3-4 h and then lyophilized (Hanneman et al. 2006; Ashline et al. 2014) . The samples were then permethylated according to reported procedures to increase the sensitivity of MS analysis (Anumula and Taylor 1992; Song et al. 2014) . Briefly, a lyophilized sample was treated with 200 µL DMSO/NaOH slurry and 200 µL methyl iodide for 30 min, shaking. The supernatant was then partitioned between 500 µL water and 500 µL chloroform. The organic layer was washed four times with 500 µL water, dried and re-dissolved in 50% methanol:water for MALDI-TOF MS analysis. Mass spectrometry data were collected using an Ultraflex MALDI TOF/TOF (Bruker Daltonics, Billerica, MA). For ESI MS and MS n analysis, AEAB was removed from the fucosyltransferase GAEAB products by incubation in 10 mM sodium hypochlorite for 30 min at room temperature resulting in a pentose proximal sugar. The reaction was quenched with the addition of formic acid, dried under a vacuum and then permethylated as described. MS data were collected using an Orbitrap Fusion (Thermo Fisher Scientific). Spray parameter was 3.5 kV. Full MS spectra were acquired with resolution of 60,000 at m/z 200 with an automatic gain control target value of 2 × 10 5 and maximum ion injection time of 100 ms.
Ions for MS/MS fragmentation were isolated in the quadrupole with an isolation window of three and analyzed in the Orbitrap analyzer. CID fragmentation was performed in the ion trap with normalized collision energy of 35, and rapid scan MS analysis. The raw data were processed using XCalibur (Thermo, San Jose).
Glycobead assay
Purified fucosyltransferase GAEAB products were conjugated to Polybead Carboxylate Microspheres (cat# 17141, 6.0 µM, Polysciences, Inc.) using the Polylink protein coupling kit (cat# 24350) with some changes. Briefly, beads were activated by suspension in 160 µL of Polylink coupling buffer (50 mM MES, 0.05% Proclin-300, pH 5.2) with the addition of 20 µL of a 200 mg/mL EDC and 200 mg/mL sulfo-NHS solution. After rotation at room temperature for 30 min, beads were washed once with Polylink wash buffer (10 mM Tris, 0.05% BSA, 0.05% Proclin-300, pH 8.0). Beads were then incubated in 1 mM GAEABs (100 mM phosphate buffer, pH 8.5) rotating, at room temperature for 1 h, washed 3× with Polylink wash buffer, and stored at 4°C until use. Biotinylated lectins and monoclonal antibodies were used to validate the beads for conjugation efficiency and for the characterization of fucosyltransferase GAEAB products. Beads were washed three times in Polylink wash buffer and incubated, rotating for 1 h with lections or mAbs (0.05 µg/mL AAL, 2.0 µg/mL RCA-I or 1 µg/mL antibody) in Binding buffer (20 mM Tris-HCl, 150 mM NaCl, 2 mM MgCl 2 , 5 mM CaCl 2 , 0.05% Tween-20, 1% BSA, pH 7.4). Beads were washed with three times with Polylink wash buffer and incubated for 1 h with Cy5-SA or anti-mouse IgG AlexaFluor 633 1:400 in Binding buffer. Beads were washed three times in Polylink wash buffer, re-suspended in water and analyzed by flow cytometry.
Schistosoma life stages
Schistosoma mansoni-infected Biomphalaria glabrata snails, strain NMRI NR-21962, were provided by the Schistosome Research Reagent Resource Center through BEI Resources, NIAID, NIH. Snail maintenance, collection of cercariae, transformation to schistosomula and isolation of adult worms from mice was conducted as previously described (Lewis 1988; Prasanphanich et al. 2014) . Briefly, snails maintained in a dark room were placed into beakers of conditioned water, under a bright light, for 2 h. The water was filtered through 70 µm nylon cell strainers to collect cercariae. After counting, the cercariae were incubated on ice for 30 min, and centrifuged at 500 × g for 10 min at 4°C. For transformation to schistosomula, the cercarial pellet was resuspended in 5-10 mL of cold DMEM and vortexed on high for 2 × 45 s periods, with a 3 min ice incubation in between; or the pellet was resuspended to 1000 cercaria/mL in cold DMEM and transformed by passage eight times though a syringe and 22-G needle, in 10 mL batches. The suspension of detached schistosomula and tails was allowed to settle and the bottom few milliliters were loaded onto a 60% Percoll gradient in DMEM. The gradient was centrifuged for 15 min at 500 × g, 4°C. The supernatant was carefully removed, and the schistosomula pellet was washed three times by spinning at 300 × g in cold DMEM. The schistosomula were cultured for 3 days in DMEM with 10% FBS, penicillin/streptomycin at a density of 500 organisms/mL in tissue-culture dishes. All work with B. glabrata and S. mansoni was approved by the Emory University Office of Occupational Health and Safety, and conducted in BSL-II animal surgery facilities and laboratories in compliance with University-approved Biosafety and IACUC protocols.
For adult worms, Swiss-Webster mice (6-8 weeks old) were obtained from the Schistosomiasis Resource Center of the Biomedical Research Institute in Rockville, MD. Female Swiss-Webster mice (4-6 weeks old) from Taconic Farms were infected with an average 200 (high dose) cercaria per mouse, and shipped to our facility. Infected mice were monitored for abdominal distention and piloerection and sacrificed if experiencing excessive stress. High-dose infected mice were sacrificed at 7.5 weeks post-infection for collection of adult worms and eggs. Euthanasia was by intraperitoneal overdose with 300 µL of 65 mg/mL sodium pentobarbital with 200 U/mL heparin sodium salt, followed by mesenteric perfusion (0.85% NaCl, 0.75% trisodium citrate dihydrate) for worm collection. Worms were washed several times with PBS. All experiments involving mice were approved by the Emory University IACUC.
Quantitative RT-PCR of FuT transcription levels
Relative transcript abundance in cercariae, newly transformed and 3-day cultured schistosomula, and adults was assessed using the comparative CT (ΔΔCT) method, where β-tubulin was used as an endogenous calibrator gene to normalize the CT values for a gene of interest. The compatibility of the tubulin calibrator and FuT primers under normal reaction conditions was assessed by plotting ΔCT at various dilutions of cDNA input and determining the slope of the resultant line, and primer efficiencies were deemed compatible if the absolute value of the slope was <0.1. Primers used in this study for qPCR are listed in Table III . Cercariae, newly transformed schistosomula, 3-day cultured schistosomula, and adult worms were washed five times with PBS and total RNA extracted using the RNAeasy kit (Qiagen) according to manufacturer's instructions. RNA was converted to first-strand cDNA using the Superscript III-First-Strand Synthesis System.
Real-time qPCR reactions (20 mL/rxn) were prepared in triplicate, comprising 1× SYBR Green PCR Master Mix (Applied Biosystems), 5 µM each forward and reverse gene-specific primers, and 15 ng RNA input-equivalents parasite cDNA. Reactions were run on a
Step One plus Real-time PCR System (Applied Biosystems) with the following cycle profile: initial denaturation at 95 o C/10 min followed by 50 cycles of 95 o C/15 s, 50 o C/11 s and 60 o C/1 min. PCR product accumulation was monitored in real time, and amplification fidelity was assessed by post-cycling thermal dissociation and electrophoretic fractionation. To assess FuT expression by the ΔΔCT method, the geometric mean of tubulin used to normalize FuT CT such that ΔCT = CT FuT -CT tubulin . Student's t-tests were used to compare α1,3-FuT expression in adults vs. cercariae and somules across three independent biological replicates, with significance set at P < #0.05.
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